FDA says Zyn can market its pouches as safer than cigarettes - Top-Institutions - MDSpire

FDA says Zyn can market its pouches as safer than cigarettes

  • By

  • Sarah Todd

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Tufts University
    Tufts University

    Medford, MA

    Key Differentiators

    • Public Health

  • #2

    American Cancer Society
    American Cancer Society

    Atlanta, GA

    Key Differentiators

    • Cancer Research
    • Public Health

  • #3

    National Institutes of Health
    National Institutes of Health

    Bethesda, MD

    Key Differentiators

    • Public Health
    • Medical Research

  • #4

    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center

    Nashville, TN

    Key Differentiators

    • Cancer Research
    • Public Health

Original Source(s)

FDA says Zyn can market its pouches as safer than cigarettes

  • by Sarah Todd

  • July 1, 2026

Related Content

The importance of robust genomic testing for patients

Misako Nagasaka, MD, PhD shared how precision oncology has fundamentally shifted the landscape through the identification of actionable genomic targets for lung cancer treatment.

  • June 25, 2026

  • 1 min
Dynamic consent framework for low-dose CT scan lung cancer screening: autonomy, privacy, ethical data management

Dana-Farber Research News 06.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from May 16 - 31.

  • by

  • June 15, 2026

  • 27 min